Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 531 institutions that hold shares in the stock, with a total of 68.7 Million shares, which have been reported (via 13F filing form) to have a value of $3.69 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Jul 30, 2025 Q2 2025 |
10,182,590
shares
|
$547 Million
4.09% of portfolio
|
Q2 2025
Added 0.17%
|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
5,593,747
shares
|
$300 Million
0.05% of portfolio
|
Q2 2025
Reduced 7.89%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
3,683,026
shares
|
$198 Million
0.11% of portfolio
|
Q2 2025
Reduced 3.03%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,270,596
shares
|
$176 Million
0.01% of portfolio
|
Q2 2025
Added 35.64%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
2,843,577
shares
|
$153 Million
0.02% of portfolio
|
Q2 2025
Added 37.25%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,777,784
shares
|
$149 Million
0.0% of portfolio
|
Q2 2024
Added 9.09%
|
|
Orbis Allan Gray LTD
Hamilton, D0 |
Aug 14, 2025 Q2 2025 |
2,764,532
shares
|
$148 Million
0.88% of portfolio
|
Q2 2025
Added 76.88%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jul 31, 2025 Q2 2025 |
2,414,838
shares
|
$130 Million
0.08% of portfolio
|
Q2 2025
Reduced 4.92%
|
|
Nikko Asset Management Americas, Inc.
|
Aug 11, 2025 Q2 2025 |
2,414,271
shares
|
$130 Million
1.25% of portfolio
|
Q2 2025
Reduced 4.95%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,298,089
shares
|
$123 Million
0.0% of portfolio
|
Q2 2025
Added 29.86%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,071,883
shares
|
$111 Million
0.01% of portfolio
|
Q2 2025
Added 98.09%
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
1,587,854
shares
|
$85.3 Million
6.4% of portfolio
|
Q4 2022
Reduced 0.14%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,545,966
shares
|
$83 Million
0.15% of portfolio
|
Q2 2025
Added 30.0%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,448,415
shares
|
$77.8 Million
0.01% of portfolio
|
Q2 2025
Added 4.45%
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,389,276
shares
|
$74.6 Million
5.82% of portfolio
|
Q1 2024
New holding
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,344,700
shares
|
$72.2 Million
0.14% of portfolio
|
Q2 2025
Added 68.68%
|
|
Sr One Capital Management, LP
|
Aug 14, 2025 Q2 2025 |
1,048,951
shares
|
$56.3 Million
18.29% of portfolio
|
Q1 2024
New holding
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
964,690
shares
|
$51.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 50.6%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
933,204
shares
|
$50.1 Million
0.01% of portfolio
|
Q2 2025
Added 30.79%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
917,712
shares
|
$49.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 2.07%
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
856,887
shares
|
$46 Million
0.05% of portfolio
|
Q2 2025
Reduced 5.82%
|
|
Contrarius Investment Management LTD
St. Helier, Y9 |
Nov 08, 2024 Q3 2024 |
783,898
shares
|
$42.1 Million
2.1% of portfolio
|
Q3 2024
Added 14.32%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
769,945
shares
|
$41.3 Million
0.01% of portfolio
|
Q2 2025
Added 164.57%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
761,115
shares
|
$40.9 Million
0.01% of portfolio
|
Q2 2025
Added 220.27%
|
|
National Bank Of Canada
|
Aug 15, 2025 Q2 2025 |
735,600
shares
|
$39.5 Million
0.04% of portfolio
|
Q2 2025
New holding
|